Department of Anesthesiology, Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, Jiangsu 210004, China.
Chin Med J (Engl). 2020 Mar 5;133(5):509-516. doi: 10.1097/CM9.0000000000000621.
In recent years, norepinephrine has attracted increasing attention for the management of maternal hypotension during elective cesarean section with spinal anesthesia. Intermittent bolus is a widely used administration paradigm for vasopressors in obstetric anesthesia in China. Thus, in this randomized, double-blinded study, we compared the efficacy and safety of equivalent bolus norepinephrine and phenylephrine for rescuing maternal post-spinal hypotension.
In a tertiary women's hospital in Nanjing, China, 102 women were allocated with computer derived randomized number to receive prophylactic 8 μg norepinephrine (group N; n = 52) or 100 μg phenylephrine (group P; n = 50) immediately post-spinal anesthesia, followed by an extra bolus of the same dosage until delivery whenever maternal systolic blood pressure became lower than 80% of the baseline. Our primary outcome was standardized maternal cardiac output (CO) reading from spinal anesthesia until delivery analyzed by a two-step method. Other hemodynamic parameters related to vasopressor efficacy and safety were considered as secondary outcomes. Maternal side effects and neonatal outcomes were collected as well.
Compared to group P, women in group N had a higher CO (standardized CO 5.8 ± 0.9 vs. 5.3 ± 1.0 L/min, t = 2.37, P = 0.02) and stroke volume (SV, standardized SV 73.6 ± 17.2 vs. 60.0 ± 13.3 mL, t = 4.52, P < 0.001), and a lower total peripheral resistance (875 ± 174 vs. 996 ± 182 dyne·s/cm, t = 3.44, P < 0.001). Furthermore, the incidence of bradycardia was lower in group N than in group P (2% vs. 14%, P = 0.023), along with an overall higher standardized heart rate (78.8 ± 11.6 vs. 75.0 ± 7.3 beats/min, P = 0.049). Other hemodynamics, as well as maternal side effects and neonatal outcomes, were similar in two groups (P > 0.05).
Compared to equivalent phenylephrine, intermittent bolus norepinephrine provides a greater CO for management of maternal hypotension during elective cesarean section with spinal anesthesia; however, no obvious maternal or neonatal clinical advantages were observed for norepinephrine.
近年来,去甲肾上腺素在椎管内麻醉下择期剖宫产术中低血压的管理中受到越来越多的关注。在中国产科麻醉中,间歇性推注是血管加压药的一种广泛应用的给药模式。因此,在这项随机、双盲研究中,我们比较了等效推注去甲肾上腺素和苯肾上腺素抢救产妇脊髓后低血压的疗效和安全性。
在中国南京的一家三级妇女医院,102 名女性通过计算机产生的随机数字分配接受预防性 8μg去甲肾上腺素(N 组,n=52)或 100μg苯肾上腺素(P 组,n=50),在脊髓麻醉后立即给药,然后在产妇收缩压低于基线的 80%时,给予相同剂量的额外推注,直至分娩。我们的主要结局是采用两步法分析从脊髓麻醉到分娩的标准化产妇心输出量(CO)读数。还考虑了与血管加压药疗效和安全性相关的其他血流动力学参数作为次要结局。收集产妇副作用和新生儿结局。
与 P 组相比,N 组的 CO 更高(标准化 CO 5.8±0.9 比 5.3±1.0 L/min,t=2.37,P=0.02),SV 更高(标准化 SV 73.6±17.2 比 60.0±13.3 mL,t=4.52,P<0.001),总外周阻力更低(875±174 比 996±182 达因·s/cm,t=3.44,P<0.001)。此外,N 组的心动过缓发生率低于 P 组(2%比 14%,P=0.023),同时,标准化心率更高(78.8±11.6 比 75.0±7.3 次/分钟,P=0.049)。两组间其他血流动力学参数、产妇副作用和新生儿结局相似(P>0.05)。
与等效苯肾上腺素相比,间歇性推注去甲肾上腺素可提供更大的 CO,用于管理椎管内麻醉下择期剖宫产术中的产妇低血压;然而,去甲肾上腺素并未显示出明显的产妇或新生儿临床优势。